Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $42.00 price target on the biotechnology company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $46.00 price objective on shares of Anavex Life […]
HC Wainwright reissued their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $42.00 price target on the biotechnology company’s stock. Separately, D. Boral Capital restated a “buy” rating and issued a $46.00 price objective on shares of Anavex Life […]
